Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays

BMC Immunology

Volumn 10, Issue , 2009, Pages 52-

  De Jager, Wilco ^a,b,c   Bourcier, Katarzyna ^d   Rijkers, Ger T ^c,e   Prakken, Berent J ^a,b,c   Seyfert Margolis, Vicki ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EUREKA Institute for Translational Medicine   (Italy)

^c Immune Tolerance Network   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD SAMPLING; CELL INTERACTION; CONTROLLED STUDY; FREEZE THAWING; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; IN VIVO STUDY; INFLAMMATION; NORMAL HUMAN; OUTCOME ASSESSMENT; RELIABILITY; REPRODUCIBILITY; STORAGE; TUBE;

BLOOD SPECIMEN COLLECTION; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; CYTOKINES; EDETIC ACID; FREEZING; HEPARIN; HUMANS; IMMUNOASSAY; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PHYTOHEMAGGLUTININS; PROTEIN STABILITY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 70449366867     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-52     Document Type: Article

References (44)

1. Chatenoud L. Immune therapies of autoimmune diseases: are we approaching a real cure?. Curr Opin Immunol 2006, 18:710-717. 10.1016/j.coi.2006.09.004, 17011768.
2. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006, 368:780-793. 10.1016/S0140-6736(06)69288-X, 16935689.
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002, 346:580-590. 10.1056/NEJMra011295, 11856798.
4. Magliocca JF, Knechtle SJ. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int 2006, 19:705-714. 10.1111/j.1432-2277.2006.00343.x, 16918530.
5. Morris PJ, Russell NK. Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation 2006, 81:1361-1367. 10.1097/01.tp.0000219235.97036.9c, 16732169.
6. Chatenoud L, Bluestone JA. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol 2007, 7:622-632. 10.1038/nri2134, 17641665.
7. Goodyear M. Learning from the TGN1412 trial. BMJ 2006, 332:677-678. 10.1136/bmj.38797.635012.47, 1410845, 16554332.
8. Mayor S. Severe adverse reactions prompt call for trial design changes. BMJ 2006, 332:683. 10.1136/bmj.332.7543.683, 1410899, 16565101.
9. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002, 2:37-45. 10.1038/nri702, 11905836.
10. Mosmann TR, Fong TA. Specific assays for cytokine production by T cells. J Immunol Methods 1989, 116:151-158. 10.1016/0022-1759(89)90198-1, 2642947.
11. de Jager W, Rijkers GT. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006, 38:294-303. 10.1016/j.ymeth.2005.11.008, 16481197.
12. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997, 43:1749-1756.
13. Selby C. Interference in immunoassay. Ann Clin Biochem 1999, 36:704-721.
14. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005, 300:124-135. 10.1016/j.jim.2005.03.009, 15896801.
15. de Jager W, Te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003, 10:133-139. 145264, 12522051.
16. Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, Gordon G. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005, 366:50-56. 10.1016/S0140-6736(05)66827-4, 15993233.
17. de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007, 66:589-598. 10.1136/ard.2006.061853, 17170049.
18. Ham HJ, de JW, Bijlsma JW, Prakken BJ, de Boer RJ. Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology (Oxford) 2009, 48:899-905. 10.1093/rheumatology/kep125, 19478039.
19. Skurkovich SV, Klinova EG, Eremkina EI, Levina NV. Immunosuppressive effect of an anti-interferon serum. Nature 1974, 247:551-552. 10.1038/247551a0, 4818554.
20. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543. 10.1126/science.1064890, 11711679.
21. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002, 359:579-580. 10.1016/S0140-6736(02)07714-0, 11867114.
22. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001, 45:27-36. 10.1002/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I, 11598944.
23. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000, 243:243-255. 10.1016/S0022-1759(00)00238-6, 10986418.
24. Petrovsky N, McNair P, Harrison LC. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998, 10:307-312. 10.1006/cyto.1997.0289, 9617577.
25. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 1998, 16:635-649. 10.3109/08830189809043012, 9646180.
26. Lissoni P, Rovelli F, Brivio F, Brivio O, Fumagalli L. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat Immun 1998, 16:1-5. 10.1159/000069464, 9789119.
27. Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 1994, 53:521-524. 10.1136/ard.53.8.521, 1005392, 7944637.
28. Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. Circadian rhythms in RA. Ann Rheum Dis 2003, 62:593-596. 10.1136/ard.62.7.593, 1754587, 12810417.
29. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002, 8:6-48.
30. Woods JA, Vieira VJ, Keylock KT. Exercise, inflammation, and innate immunity. Neurol Clin 2006, 24:585-599. 10.1016/j.ncl.2006.03.008, 16877125.
31. Duvigneau JC, Hartl RT, Teinfalt M, Gemeiner M. Delay in processing porcine whole blood affects cytokine expression. J Immunol Methods 2003, 272:11-21. 10.1016/S0022-1759(02)00372-1, 12505708.
32. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994, 34:20-25. 10.1046/j.1537-2995.1994.34194098597.x, 8273124.
33. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195. 10.1073/pnas.97.3.1190, 15564, 10655506.
34. Svenson M, Hansen MB, Heegaard P, Abell K, Bendtzen K. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I. Cytokine 1993, 5:427-435. 10.1016/1043-4666(93)90032-Z, 8142597.
35. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999, 6:89-95. 95666, 9874670.
36. Martins TB. Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diagn Lab Immunol 2002, 9:41-45. 119915, 11777827.
37. Hulse RE, Kunkler PE, Fedynyshyn JP, Kraig RP. Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods 2004, 136:87-98. 10.1016/j.jneumeth.2003.12.023, 15126049.
38. Phillips DJ, League SC, Weinstein P, Hooper WC. Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation. Cytokine 2006, 36:180-188. 10.1016/j.cyto.2006.12.002, 17306558.
39. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry 2004, 61B:35-39.
40. Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS ONE 2008, 3:e2535. 10.1371/journal.pone.0002535, 2432042, 18596971.
41. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999, 45:942-956.
42. Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 2004, 11:325-329. 371198, 15013983.
43. Pfleger C, Schloot N, ter VF. Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays. J Immunol Methods 2008, 329:214-218. 10.1016/j.jim.2007.09.011, 17964594.
44. Svenson M, Hansen MB, Kayser L, Rasmussen AK, Reimert CM, Bendtzen K. Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1. Cytokine 1992, 4:125-133. 10.1016/1043-4666(92)90047-U, 1385986.